Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03422536
Title Ficlatuzumab With or Without Cetuximab in Treating Patients With Cetuximab-Resistant, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Arizona
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Arizona Cancer Center Tucson Arizona 85719 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field